KYMBERLY KUHNS: Open Payments
NPI 1801288709 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 20 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $85 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $279 |
| Vanda Pharmaceuticals Inc. | 4 | $224 |
| Axsome Therapeutics, Inc. | 5 | $143 |
| Alkermes, Inc. | 4 | $142 |
| Otsuka America Pharmaceutical, Inc. | 1 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
Products named: COBENFY, FANAPT, Auvelity, ARISTADA, REXULTI, CAPLYTA, VRAYLAR, HETLIOZ.
Industry payments across TN — which companies pay providers there.
